Fri, 28 February 2014
The discussion of verapamil as an option for the treatment of supraventricular tachycardia (SVT) in RAGE Session Two went off like a fire cracker in the FOAM world.
In this RAGEback, Minh Le Cong from the PHARM podcast explains why the RAGE discussion is not going to change his practice, which is to use adenosine as a first line agent.
This is followed by a response by RAGErs Karel and Cliff.
You — the listener — are left to make up your own mind about which patients (if any) you’ll consider verapamil as an option.